2025 Q1 Form 10-K Financial Statement

#000168875725000019 Filed on February 28, 2025

View on sec.gov

Income Statement

Concept 2025 Q1 2024 Q4 2024
Revenue $166.0M
YoY Change 0.53%
Cost Of Revenue $56.50M
YoY Change -2.88%
Gross Profit $109.5M
YoY Change 2.38%
Gross Profit Margin 65.97%
Selling, General & Admin $139.8M
YoY Change -3.96%
% of Gross Profit 127.65%
Research & Development $19.71M
YoY Change -25.44%
% of Gross Profit 17.99%
Depreciation & Amortization $4.700M
YoY Change 67.86%
% of Gross Profit 4.29%
Operating Expenses $159.5M
YoY Change -7.26%
Operating Profit -$49.99M
YoY Change -23.13%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$15.29M
YoY Change -1973.65%
Pretax Income -$84.63M
YoY Change 7.69%
Income Tax -$32.00K
% Of Pretax Income
Net Earnings -$84.60M
YoY Change 7.76%
Net Earnings / Revenue -50.95%
Basic Earnings Per Share -$3.00
Diluted Earnings Per Share -$3.00
COMMON SHARES
Basic Shares Outstanding 28.85M shares 28.00M shares 28.16M shares
Diluted Shares Outstanding 28.16M shares

Balance Sheet

Concept 2025 Q1 2024 Q4 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $90.35M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $78.77M
Prepaid Expenses
Receivables $65.00M
Other Receivables
Total Short-Term Assets $243.0M
YoY Change 38.96%
LONG-TERM ASSETS
Property, Plant & Equipment $78.03M
YoY Change 1.07%
Goodwill $1.209M
YoY Change 160.0%
Intangibles $11.68M
YoY Change 46.28%
Long-Term Investments
YoY Change
Other Assets $7.313M
YoY Change 55.53%
Total Long-Term Assets $103.8M
YoY Change 10.73%
TOTAL ASSETS
Total Short-Term Assets $243.0M
Total Long-Term Assets $103.8M
Total Assets $346.8M
YoY Change 29.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $44.76M
YoY Change 7.53%
Accrued Expenses $16.54M
YoY Change 20.79%
Deferred Revenue $1.749M
YoY Change -4.74%
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $68.28M
YoY Change 19.47%
LONG-TERM LIABILITIES
Long-Term Debt $219.6M
YoY Change 16.34%
Other Long-Term Liabilities $1.678M
YoY Change 2.01%
Total Long-Term Liabilities $221.3M
YoY Change 16.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $68.28M
Total Long-Term Liabilities $221.3M
Total Liabilities $293.7M
YoY Change 17.38%
SHAREHOLDERS EQUITY
Retained Earnings -$444.7M
YoY Change 23.49%
Common Stock $420.4M
YoY Change 33.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $53.10M
YoY Change
Total Liabilities & Shareholders Equity $346.8M
YoY Change 29.11%

Cashflow Statement

Concept 2025 Q1 2024 Q4 2024
OPERATING ACTIVITIES
Net Income -$84.60M
YoY Change 7.76%
Depreciation, Depletion And Amortization $4.700M
YoY Change 67.86%
Cash From Operating Activities -$58.52M
YoY Change -33.89%
INVESTING ACTIVITIES
Capital Expenditures $6.114M
YoY Change -22.69%
Acquisitions $50.00K
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$15.61M
YoY Change -36.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $99.48M
YoY Change 17.68%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $125.9M
YoY Change 46.0%
NET CHANGE
Cash From Operating Activities -$58.52M
Cash From Investing Activities -$15.61M
Cash From Financing Activities $125.9M
Net Change In Cash $50.31M
YoY Change -291.16%
FREE CASH FLOW
Cash From Operating Activities -$58.52M
Capital Expenditures $6.114M
Free Cash Flow -$64.63M
YoY Change -32.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-75209000 usd
CY2024 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1722000 usd
CY2023 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
2907000 usd
CY2024 esta Noncash Or Part Noncash Acquisition Noncash Equity Instrument Consideration
NoncashOrPartNoncashAcquisitionNoncashEquityInstrumentConsideration
0 usd
CY2023 esta Noncash Or Part Noncash Acquisition Noncash Equity Instrument Consideration
NoncashOrPartNoncashAcquisitionNoncashEquityInstrumentConsideration
250000 usd
CY2024 dei City Area Code
CityAreaCode
24
CY2024 dei Local Phone Number
LocalPhoneNumber
34 2400
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001688757
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity File Number
EntityFileNumber
001-38593
CY2024 dei Entity Registrant Name
EntityRegistrantName
Establishment Labs Holdings Inc.
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
D8
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1436377
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
Building B23 and B25
CY2024 dei Entity Address Address Line2
EntityAddressAddressLine2
Coyol Free Zone
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
Alajuela
CY2024 dei Entity Address Country
EntityAddressCountry
CR
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Small Business
EntitySmallBusiness
false
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Public Float
EntityPublicFloat
844731145 usd
CY2025Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28845813 shares
CY2024 dei Trading Symbol
TradingSymbol
ESTA
CY2024 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024 cyd Cybersecurity Risk Management Positions Or Committees Responsible Flag
CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag
true
CY2024 dei Country Region
CountryRegion
506
CY2024Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-12-31
CY2024 dei Security12b Title
Security12bTitle
Common Shares, No Par Value
CY2024 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024 cyd Cybersecurity Risk Management Positions Or Committees Responsible Report To Board Flag
CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag
true
CY2024 cyd Cybersecurity Risk Management Processes Integrated Flag
CybersecurityRiskManagementProcessesIntegratedFlag
true
CY2024 cyd Cybersecurity Risk Third Party Oversight And Identification Processes Flag
CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag
true
CY2024 cyd Cybersecurity Risk Management Third Party Engaged Flag
CybersecurityRiskManagementThirdPartyEngagedFlag
true
CY2024 cyd Cybersecurity Risk Materially Affected Or Reasonably Likely To Materially Affect Registrant Flag
CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag
false
CY2024Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024 ecd Insider Trd Policies Proc Adopted Flag
InsiderTrdPoliciesProcAdoptedFlag
true
CY2024 dei Auditor Name
AuditorName
Marcum LLP
CY2024 dei Auditor Firm
AuditorFirmId
688
CY2024 dei Auditor Location
AuditorLocation
Los Angeles, California
CY2024Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
90347000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40035000 usd
CY2024Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3088000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1841000 usd
CY2024Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
65002000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
46918000 usd
CY2024Q4 us-gaap Inventory Net
InventoryNet
78766000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
79471000 usd
CY2024Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8922000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8477000 usd
CY2024Q4 us-gaap Assets Current
AssetsCurrent
243037000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
174901000 usd
CY2024Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78028000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
77205000 usd
CY2024Q4 us-gaap Goodwill
Goodwill
1209000 usd
CY2024Q4 us-gaap Goodwill
Goodwill
1209000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
465000 usd
CY2024Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11683000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7987000 usd
CY2024Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5561000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3381000 usd
CY2024Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7313000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4702000 usd
CY2024Q4 us-gaap Assets
Assets
346831000 usd
CY2023Q4 us-gaap Assets
Assets
268641000 usd
CY2024Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
44760000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
41624000 usd
CY2024Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16536000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13690000 usd
CY2024Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6982000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1836000 usd
CY2024Q4 us-gaap Liabilities Current
LiabilitiesCurrent
68278000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
57150000 usd
CY2024Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
219577000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
188739000 usd
CY2024Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4203000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2712000 usd
CY2024Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1678000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1645000 usd
CY2024Q4 us-gaap Liabilities
Liabilities
293736000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
250246000 usd
CY2024Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29195439 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26495250 shares
CY2024Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28787369 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26087180 shares
CY2024Q4 us-gaap Common Stock Value
CommonStockValue
420364000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
315634000 usd
CY2024Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
76992000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63748000 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
408070 shares
CY2024Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
408070 shares
CY2024Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
2854000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
2854000 usd
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-444692000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-360096000 usd
CY2024Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3285000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1963000 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
53095000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
18395000 usd
CY2024Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
346831000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
268641000 usd
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
166025000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
165151000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
161700000 usd
CY2024 us-gaap Cost Of Revenue
CostOfRevenue
56500000 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
58174000 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
55105000 usd
CY2024 us-gaap Gross Profit
GrossProfit
109525000 usd
CY2023 us-gaap Gross Profit
GrossProfit
106977000 usd
CY2022 us-gaap Gross Profit
GrossProfit
106595000 usd
CY2024 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
139806000 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
145575000 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
125984000 usd
CY2024 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19706000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26428000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20269000 usd
CY2024 us-gaap Operating Expenses
OperatingExpenses
159512000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
172003000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
146253000 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-49987000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-65026000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-39658000 usd
CY2024 us-gaap Investment Income Interest
InvestmentIncomeInterest
1477000 usd
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
1020000 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
87000 usd
CY2024 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
20829000 usd
CY2023 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
15393000 usd
CY2022 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
11760000 usd
CY2024 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
CY2023 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
CY2022 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
703000 usd
CY2024 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-19019000 usd
CY2024 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15289000 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
816000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3177000 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-84628000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-78583000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-72824000 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-32000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-81000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2385000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-84596000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-78502000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-75209000 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.00
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.00
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.07
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.07
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.08
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.08
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28161761 shares
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28161761 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25600029 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25600029 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24457793 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24457793 shares
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-84596000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-78502000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-75209000 usd
CY2024 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1322000 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-752000 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-942000 usd
CY2024 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1322000 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-752000 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-942000 usd
CY2024 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-83274000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-79254000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-76151000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
50739000 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3873000 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13358000 usd
CY2022 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4000 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-942000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-75209000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-8185000 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
84538000 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
745000 usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6673000 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14362000 usd
CY2023 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
484000 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-752000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-78502000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
18395000 usd
CY2024 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
99484000 usd
CY2024 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2142000 usd
CY2024 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 usd
CY2024 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2454000 usd
CY2024 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14404000 usd
CY2024 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
510000 usd
CY2024 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1322000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-84596000 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
53095000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-84596000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-78502000 usd
CY2024 esta Depreciation And Amortization Excluding Debt Discount Premium
DepreciationAndAmortizationExcludingDebtDiscountPremium
6834000 usd
CY2023 esta Depreciation And Amortization Excluding Debt Discount Premium
DepreciationAndAmortizationExcludingDebtDiscountPremium
4166000 usd
CY2022 esta Depreciation And Amortization Excluding Debt Discount Premium
DepreciationAndAmortizationExcludingDebtDiscountPremium
3870000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1223000 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
111000 usd
CY2024 us-gaap Inventory Write Down
InventoryWriteDown
1805000 usd
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
1392000 usd
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
1577000 usd
CY2024 esta Property Plant And Equipment Write Down
PropertyPlantAndEquipmentWriteDown
0 usd
CY2023 esta Property Plant And Equipment Write Down
PropertyPlantAndEquipmentWriteDown
-341000 usd
CY2022 esta Property Plant And Equipment Write Down
PropertyPlantAndEquipmentWriteDown
341000 usd
CY2024 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2178000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3706000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
86000 usd
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
14404000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
14362000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
13358000 usd
CY2024 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-163000 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-280000 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-229000 usd
CY2024 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-5302000 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
4181000 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-1732000 usd
CY2024 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-19019000 usd
CY2024 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
743000 usd
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
717000 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
469000 usd
CY2024 esta Gain Loss On Write Off Of Deferred Tax Liability Share Based Payment Arrangement
GainLossOnWriteOffOfDeferredTaxLiabilityShareBasedPaymentArrangement
0 usd
CY2023 esta Gain Loss On Write Off Of Deferred Tax Liability Share Based Payment Arrangement
GainLossOnWriteOffOfDeferredTaxLiabilityShareBasedPaymentArrangement
0 usd
CY2022 esta Gain Loss On Write Off Of Deferred Tax Liability Share Based Payment Arrangement
GainLossOnWriteOffOfDeferredTaxLiabilityShareBasedPaymentArrangement
1866000 usd
CY2024 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0 usd
CY2023 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0 usd
CY2022 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
703000 usd
CY2024 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
-6004000 usd
CY2023 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 usd
CY2022 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 usd
CY2024 esta Stock Compensation Issued In Lieu Of Cash Fees
StockCompensationIssuedInLieuOfCashFees
964000 usd
CY2023 esta Stock Compensation Issued In Lieu Of Cash Fees
StockCompensationIssuedInLieuOfCashFees
495000 usd
CY2022 esta Stock Compensation Issued In Lieu Of Cash Fees
StockCompensationIssuedInLieuOfCashFees
0 usd
CY2024 esta Interest Costs Capitalized Construction In Progress
InterestCostsCapitalizedConstructionInProgress
555000 usd
CY2023 esta Interest Costs Capitalized Construction In Progress
InterestCostsCapitalizedConstructionInProgress
3567000 usd
CY2022 esta Interest Costs Capitalized Construction In Progress
InterestCostsCapitalizedConstructionInProgress
1762000 usd
CY2024 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6371000 usd
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
13278000 usd
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
8124000 usd
CY2024 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
26278000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11557000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12333000 usd
CY2024 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
471000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
42230000 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10900000 usd
CY2024 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-86000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2637000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4489000 usd
CY2024 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
483000 usd
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-318000 usd
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
750000 usd
CY2024 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6671000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
18957000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4376000 usd
CY2024 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4395000 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1662000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2815000 usd
CY2024 esta Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-646000 usd
CY2023 esta Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-689000 usd
CY2022 esta Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-378000 usd
CY2024 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1227000 usd
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
97000 usd
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
117000 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-58516000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-88513000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-52166000 usd
CY2024 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6114000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7908000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2851000 usd
CY2024 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
50000 usd
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2024 esta Paymentsto Acquire Assets Including Receivables Held
PaymentstoAcquireAssetsIncludingReceivablesHeld
0 usd
CY2023 esta Paymentsto Acquire Assets Including Receivables Held
PaymentstoAcquireAssetsIncludingReceivablesHeld
0 usd
CY2022 esta Paymentsto Acquire Assets Including Receivables Held
PaymentstoAcquireAssetsIncludingReceivablesHeld
525000 usd
CY2024 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
7033000 usd
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1328000 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1491000 usd
CY2024 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
2414000 usd
CY2023 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
15311000 usd
CY2022 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
29924000 usd
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15611000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24547000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-34791000 usd
CY2024 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
99484000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
84538000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2024 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
24467000 usd
CY2023 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 usd
CY2022 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
168093000 usd
CY2024 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
CY2023 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
CY2022 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
71681000 usd
CY2024 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 usd
CY2023 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 usd
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
26000 usd
CY2024 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2454000 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2173000 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3873000 usd
CY2024 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
510000 usd
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
484000 usd
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4000 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
125895000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
86227000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
100255000 usd
CY2024 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1456000 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
513000 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-358000 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
50312000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-26320000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12940000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40035000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66355000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53415000 usd
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
90347000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40035000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66355000 usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
9806000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
5689000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
5363000 usd
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1735000 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2165000 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2125000 usd
CY2024 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
240000 usd
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2847000 usd
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1129000 usd
CY2024 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
592000 usd
CY2022 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
0 usd
CY2022 esta Noncash Or Part Noncash Acquisition Noncash Equity Instrument Consideration
NoncashOrPartNoncashAcquisitionNoncashEquityInstrumentConsideration
0 usd
CY2024 us-gaap Stock Issued1
StockIssued1
1177000 usd
CY2023 us-gaap Stock Issued1
StockIssued1
0 usd
CY2022 us-gaap Stock Issued1
StockIssued1
0 usd
CY2024 esta Noncash Or Part Noncash Business Combination Contingent Consideration Arrangements Liability
NoncashOrPartNoncashBusinessCombinationContingentConsiderationArrangementsLiability
973000 usd
CY2023 esta Noncash Or Part Noncash Business Combination Contingent Consideration Arrangements Liability
NoncashOrPartNoncashBusinessCombinationContingentConsiderationArrangementsLiability
0 usd
CY2022 esta Noncash Or Part Noncash Business Combination Contingent Consideration Arrangements Liability
NoncashOrPartNoncashBusinessCombinationContingentConsiderationArrangementsLiability
0 usd
CY2024 esta Noncash Or Part Noncash Consideration Payable Related To Business Acquisition
NoncashOrPartNoncashConsiderationPayableRelatedToBusinessAcquisition
3262000 usd
CY2023 esta Noncash Or Part Noncash Consideration Payable Related To Business Acquisition
NoncashOrPartNoncashConsiderationPayableRelatedToBusinessAcquisition
0 usd
CY2022 esta Noncash Or Part Noncash Consideration Payable Related To Business Acquisition
NoncashOrPartNoncashConsiderationPayableRelatedToBusinessAcquisition
0 usd
CY2024 esta Noncash Proceeds From Stock Options Exercised
NoncashProceedsFromStockOptionsExercised
0 usd
CY2023 esta Noncash Proceeds From Stock Options Exercised
NoncashProceedsFromStockOptionsExercised
4500000 usd
CY2022 esta Noncash Proceeds From Stock Options Exercised
NoncashProceedsFromStockOptionsExercised
0 usd
CY2024 esta Noncash Or Part Noncash Warrants Exercised
NoncashOrPartNoncashWarrantsExercised
600000 usd
CY2023 esta Noncash Or Part Noncash Warrants Exercised
NoncashOrPartNoncashWarrantsExercised
0 usd
CY2022 esta Noncash Or Part Noncash Warrants Exercised
NoncashOrPartNoncashWarrantsExercised
0 usd
CY2024 esta Cash Payable To Settle Contract Termination
CashPayableToSettleContractTermination
214000 usd
CY2023 esta Cash Payable To Settle Contract Termination
CashPayableToSettleContractTermination
0 usd
CY2022 esta Cash Payable To Settle Contract Termination
CashPayableToSettleContractTermination
0 usd
CY2024 esta Noncash Or Part Noncash Liability To Issue Shares To Settle Contract Termination
NoncashOrPartNoncashLiabilityToIssueSharesToSettleContractTermination
1320000 usd
CY2023 esta Noncash Or Part Noncash Liability To Issue Shares To Settle Contract Termination
NoncashOrPartNoncashLiabilityToIssueSharesToSettleContractTermination
0 usd
CY2022 esta Noncash Or Part Noncash Liability To Issue Shares To Settle Contract Termination
NoncashOrPartNoncashLiabilityToIssueSharesToSettleContractTermination
0 usd
CY2024Q4 esta Number Of Manufacturing Facilities
NumberOfManufacturingFacilities
2 facility
CY2024 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> financial statements and accompanying notes. Significant accounting </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimates and management judgments reflected in the consolidated financial statements include items such as accounts receivable valuation and allowances, inventory valuation and allowances, valuation of acquired intangible assets and valuation of deferred income tax assets, including tax valuation allowances. Estimates are based</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.</span></div>
CY2024 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and accounts receivable. The majority of the Company’s cash is held at two financial institutions in the United States. Balances in the Company’s cash accounts exceed the Federal Deposit Insurance Corporation, or FDIC, limit of $250,000. The Company has not experienced any losses to its deposits of cash. </span></div><div style="margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company’s revenue has been derived from sales of its products in international markets, principally Europe, the Middle East, Latin America, and Asia. In the international markets in which the Company operates, the Company uses a combination of distributors and direct sales to customers. The Company performs ongoing credit evaluations of its distributors and customers, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company’s revenues were derived from the sale of Motiva Implants. During the years ended December 31, 2024, 2023 and 2022, no customer accounted for more than 10% of the Company’s revenue. One customer accounted for 17.0% of the Company’s trade accounts receivable balance as of December 31, 2024. Two customers accounted for 12.7% and 11.6% of the Company’s trade accounts receivable balance as of December 31, 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on Avantor, Inc. (formerly NuSil Technology, LLC), or Avantor, as the sole supplier of medical-grade silicone used in Motiva Implants. During the years ended December 31, 2024, 2023 and 2022, the Company had purchases of $29.2 million, or 44.7% of total purchases, $53.7 million, or 68.4% of total purchases, and $32.1 million or 38.2% of total purchases, respectively, from Avantor. As of December 31, 2024 and 2023, the Company had an outstanding balance owed to this vendor of $15.0 million and $5.3 million, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s financial condition and future results of operations involve a number of risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, unfavorable economic conditions, uncertainty of continued or new regulatory approval for the Company’s current and potential future products, uncertainty of market acceptance of the Company’s products, competition from substitute products and larger companies, securing and protecting proprietary technology, access to capital, strategic relationships and dependence on key individuals and sole source suppliers. </span></div>Products developed by the Company require clearance from the FDA or other international regulatory agencies prior to commercial sales. There can be no assurance that the products will receive the necessary clearances. If the Company is denied clearance, clearance is delayed, or the Company is unable to maintain its existing clearances, these developments could have a material adverse impact on the Company.
CY2024Q4 esta Number Of Financial Institutions Holding Cash
NumberOfFinancialInstitutionsHoldingCash
2 financial_institution
CY2024Q4 esta Number Of Financial Institutions Holding Cash
NumberOfFinancialInstitutionsHoldingCash
2 financial_institution
CY2024Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
3000000.0 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
2800000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1841000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
741000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1221000 usd
CY2024 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1722000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1223000 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
111000 usd
CY2024 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
475000 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
123000 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
591000 usd
CY2024Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3088000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1841000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
741000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3930000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2649000 usd
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1167000 usd
CY2024 us-gaap Inventory Write Down
InventoryWriteDown
1805000 usd
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
1392000 usd
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
1577000 usd
CY2024 esta Inventory Write Off
InventoryWriteOff
1558000 usd
CY2023 esta Inventory Write Off
InventoryWriteOff
111000 usd
CY2022 esta Inventory Write Off
InventoryWriteOff
95000 usd
CY2024Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4177000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3930000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2649000 usd
CY2024 esta Revenue From Contract With Customer Product Return Period
RevenueFromContractWithCustomerProductReturnPeriod
P15D
CY2024Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
400000 usd
CY2023Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
300000 usd
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
166025000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
165151000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
161700000 usd
CY2024 esta Revenue From Contract With Customer Product Shelf Life
RevenueFromContractWithCustomerProductShelfLife
P5Y
CY2024 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 unit
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2024 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2022 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2024 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2024 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-8800000 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1800000 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3000000.0 usd
CY2024Q4 esta Contract Termination Costs Settled Accounts Receivable
ContractTerminationCostsSettledAccountsReceivable
5700000 usd
CY2024Q4 esta Contract Termination Costs Settled Accounts Payable
ContractTerminationCostsSettledAccountsPayable
1300000 usd
CY2024Q4 esta Contract Termination Costs Settled Net
ContractTerminationCostsSettledNet
4500000 usd
CY2024Q4 esta Contract Termination Costs Payable
ContractTerminationCostsPayable
1500000 usd
CY2024 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
-6000000 usd
CY2024 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior year amounts to conform to the current year presentation. These reclassifications had no material impact on the Company’s financial position as of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2024</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or results of operations for year ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2024</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div>
CY2024Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
41310000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
40663000 usd
CY2024Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2454000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1727000 usd
CY2024Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
35002000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
37081000 usd
CY2024Q4 us-gaap Inventory Net
InventoryNet
78766000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
79471000 usd
CY2024Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
9000000 usd
CY2023Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
7100000 usd
CY2024Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2768000 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2747000 usd
CY2024Q4 esta Prepaid Services Current
PrepaidServicesCurrent
571000 usd
CY2023Q4 esta Prepaid Services Current
PrepaidServicesCurrent
420000 usd
CY2024Q4 us-gaap Prepaid Taxes
PrepaidTaxes
458000 usd
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
1073000 usd
CY2024Q4 esta Prepaid Assets Current
PrepaidAssetsCurrent
505000 usd
CY2023Q4 esta Prepaid Assets Current
PrepaidAssetsCurrent
394000 usd
CY2024Q4 us-gaap Supplies
Supplies
1005000 usd
CY2023Q4 us-gaap Supplies
Supplies
468000 usd
CY2024Q4 esta Prepaid Clinical Trial Costs Current
PrepaidClinicalTrialCostsCurrent
184000 usd
CY2023Q4 esta Prepaid Clinical Trial Costs Current
PrepaidClinicalTrialCostsCurrent
176000 usd
CY2024Q4 esta Prepaid Warranty And Distribution Rights Current
PrepaidWarrantyAndDistributionRightsCurrent
409000 usd
CY2023Q4 esta Prepaid Warranty And Distribution Rights Current
PrepaidWarrantyAndDistributionRightsCurrent
275000 usd
CY2024Q4 esta Prepaid Software
PrepaidSoftware
408000 usd
CY2023Q4 esta Prepaid Software
PrepaidSoftware
506000 usd
CY2024Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2614000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2418000 usd
CY2024Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8922000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8477000 usd
CY2024Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
98144000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
93532000 usd
CY2024Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20116000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16327000 usd
CY2024Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78028000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
77205000 usd
CY2024 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4700000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2800000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2500000 usd
CY2024Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
6235000 usd
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
4451000 usd
CY2024Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
4832000 usd
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
5223000 usd
CY2024Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1514000 usd
CY2024Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1514000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
773000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
773000 usd
CY2024Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
1312000 usd
CY2023Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
344000 usd
CY2024Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
876000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1269000 usd
CY2024Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
141000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
119000 usd
CY2024Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
153000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
109000 usd
CY2024Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1473000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1402000 usd
CY2024Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16536000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13690000 usd
CY2024Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1749000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1836000 usd
CY2024Q4 esta Business Combination Consideration Payable Current
BusinessCombinationConsiderationPayableCurrent
2774000 usd
CY2023Q4 esta Business Combination Consideration Payable Current
BusinessCombinationConsiderationPayableCurrent
0 usd
CY2024Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
737000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 usd
CY2024Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
1722000 usd
CY2023Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
0 usd
CY2024Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6982000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1836000 usd
CY2024Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1124000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1498000 usd
CY2024Q4 esta Business Combination Consideration Payable Noncurrent
BusinessCombinationConsiderationPayableNoncurrent
278000 usd
CY2023Q4 esta Business Combination Consideration Payable Noncurrent
BusinessCombinationConsiderationPayableNoncurrent
0 usd
CY2024Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
174000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0 usd
CY2024Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
102000 usd
CY2023Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
147000 usd
CY2024Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1678000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1645000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
465000 usd
CY2024 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
744000 usd
CY2024 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024Q4 us-gaap Goodwill
Goodwill
1209000 usd
CY2024Q4 us-gaap Goodwill
Goodwill
1209000 usd
CY2024Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
20526000 usd
CY2024Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8843000 usd
CY2024Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11683000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
14451000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6464000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7987000 usd
CY2024 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000 usd
CY2024Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2785000 usd
CY2024Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2320000 usd
CY2024Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2091000 usd
CY2024Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1944000 usd
CY2024Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
950000 usd
CY2024Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
937000 usd
CY2024Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11027000 usd
CY2024 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2024Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
973000 usd
CY2024Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
973000 usd
CY2024Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1000000 usd
CY2024Q1 esta Debt Instrument Number Of Remaining Available Tranches
DebtInstrumentNumberOfRemainingAvailableTranches
2 tranche
CY2022Q2 esta Number Of Tranches
NumberOfTranches
4 tranche
CY2024Q4 us-gaap Long Term Debt
LongTermDebt
0 usd
CY2024 us-gaap Operating Lease Cost
OperatingLeaseCost
1481000 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
1079000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
740000 usd
CY2024 us-gaap Sublease Income
SubleaseIncome
311000 usd
CY2023 us-gaap Sublease Income
SubleaseIncome
233000 usd
CY2022 us-gaap Sublease Income
SubleaseIncome
0 usd
CY2024 us-gaap Lease Cost
LeaseCost
1170000 usd
CY2023 us-gaap Lease Cost
LeaseCost
846000 usd
CY2022 us-gaap Lease Cost
LeaseCost
740000 usd
CY2024Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5561000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3381000 usd
CY2024Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1514000 usd
CY2024Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1514000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
773000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
773000 usd
CY2024Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4203000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2712000 usd
CY2024Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5717000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3485000 usd
CY2024Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M24D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y7M6D
CY2024Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.111
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.093
CY2024 us-gaap Operating Lease Payments
OperatingLeasePayments
1384000 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
1052000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
649000 usd
CY2024 us-gaap Proceeds From Lease Payments
ProceedsFromLeasePayments
320000 usd
CY2023 us-gaap Proceeds From Lease Payments
ProceedsFromLeasePayments
214000 usd
CY2022 us-gaap Proceeds From Lease Payments
ProceedsFromLeasePayments
0 usd
CY2024 esta Operating Lease Payments Net Of Sublease Income
OperatingLeasePaymentsNetOfSubleaseIncome
1064000 usd
CY2023 esta Operating Lease Payments Net Of Sublease Income
OperatingLeasePaymentsNetOfSubleaseIncome
838000 usd
CY2022 esta Operating Lease Payments Net Of Sublease Income
OperatingLeasePaymentsNetOfSubleaseIncome
649000 usd
CY2024 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3115000 usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
478000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1962000 usd
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2024000 usd
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1923000 usd
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1653000 usd
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
836000 usd
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
432000 usd
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
99000 usd
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6967000 usd
CY2024Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1250000 usd
CY2024Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5717000 usd
CY2024Q4 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
332000 usd
CY2024Q4 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
343000 usd
CY2024Q4 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
355000 usd
CY2024Q4 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
368000 usd
CY2024Q4 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
315000 usd
CY2024Q4 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
0 usd
CY2024Q4 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
1713000 usd
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29195439 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26495250 shares
CY2024Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28787369 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26087180 shares
CY2023Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
84600000 usd
CY2024Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
5626275 shares
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
5672448 shares
CY2024 esta Class Of Warrant Or Right Exercises In Period Net
ClassOfWarrantOrRightExercisesInPeriodNet
600000 shares
CY2024Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
599991 shares
CY2023 esta Class Of Warrant Or Right Exercises In Period Net
ClassOfWarrantOrRightExercisesInPeriodNet
0 shares
CY2024Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
626589 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2024 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14404000 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14362000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13358000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1487387 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
47.47
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M7D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4308000 usd
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
33.47
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
226525 shares
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
46.71
CY2024 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
134226 shares
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
18.28
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
165738 shares
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
67.26
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1413948 shares
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
47.96
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M18D
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
14010000 usd
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
997185 shares
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
43.28
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
13400000 usd
CY2024 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
134226 shares
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
18.28
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4100000 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5100000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
15000000 usd
CY2024Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
9600000 usd
CY2024 esta Employee And Non Employee Service Share Based Compensation Nonvested Awards Compensation Cost Not Yet Recognized Period For Recognition
EmployeeAndNonEmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedPeriodForRecognition
P2Y1M6D
CY2024Q4 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
0 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-60665000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-13556000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-9721000 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-23963000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-65027000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-63103000 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-84628000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-78583000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-72824000 usd
CY2024 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
183000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
297000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
114000 usd
CY2024 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1963000 usd
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
3328000 usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
2185000 usd
CY2024 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2146000 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3625000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2299000 usd
CY2024 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2024 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-2178000 usd
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-3706000 usd
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
86000 usd
CY2024 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2178000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3706000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
86000 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-32000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-81000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2385000 usd
CY2024 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-25388000 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.300
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-23575000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.300
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-21847000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.300
CY2024 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
7166000 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.085
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
18070000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.229
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
15978000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.220
CY2024 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-446000 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.005
CY2023 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-7000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
104000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2024 esta Effective Income Tax Rate Reconciliation Return To Provision Adjustment Amount
EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount
-561000 usd
CY2024 esta Effective Income Tax Rate Reconciliation Return To Provision Adjustment Percent
EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentPercent
0.007
CY2023 esta Effective Income Tax Rate Reconciliation Return To Provision Adjustment Amount
EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount
-539000 usd
CY2023 esta Effective Income Tax Rate Reconciliation Return To Provision Adjustment Percent
EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentPercent
0.007
CY2022 esta Effective Income Tax Rate Reconciliation Return To Provision Adjustment Amount
EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount
2651000 usd
CY2022 esta Effective Income Tax Rate Reconciliation Return To Provision Adjustment Percent
EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentPercent
-0.040
CY2024 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
0 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0
CY2023 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
0 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0
CY2022 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
52000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0
CY2024 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-14157000 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.167
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
438000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.006
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3573000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.050
CY2024 esta Effective Income Tax Rate Reconciliation Tax Holiday Adjustment Expense Benefit
EffectiveIncomeTaxRateReconciliationTaxHolidayAdjustmentExpenseBenefit
-18373000 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation Tax Holidays
EffectiveIncomeTaxRateReconciliationTaxHolidays
0.217
CY2023 esta Effective Income Tax Rate Reconciliation Tax Holiday Adjustment Expense Benefit
EffectiveIncomeTaxRateReconciliationTaxHolidayAdjustmentExpenseBenefit
-4386000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Holidays
EffectiveIncomeTaxRateReconciliationTaxHolidays
0.056
CY2022 esta Effective Income Tax Rate Reconciliation Tax Holiday Adjustment Expense Benefit
EffectiveIncomeTaxRateReconciliationTaxHolidayAdjustmentExpenseBenefit
-3030000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Holidays
EffectiveIncomeTaxRateReconciliationTaxHolidays
0.040
CY2024 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
227000 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.003
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
984000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.013
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-1353000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.020
CY2024 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
14744000 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.174
CY2023 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
0 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0
CY2022 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
0 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0
CY2024 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
10000 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
162000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.002
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
301000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-32000 usd
CY2024 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-81000 usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.001
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2385000 usd
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.030
CY2024Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
563000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
567000 usd
CY2024Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1036000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
0 usd
CY2024Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
105000 usd
CY2023Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
125000 usd
CY2024Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3763000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
661000 usd
CY2024Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
10742000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
25087000 usd
CY2024Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
325000 usd
CY2023Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
336000 usd
CY2024Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
649000 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
297000 usd
CY2024Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9223000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
23380000 usd
CY2024Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
5888000 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
3693000 usd
CY2024Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
500000 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.30
CY2024Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
100000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-84596000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-78502000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-75209000 usd
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28161761 shares
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28161761 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25600029 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25600029 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24457793 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24457793 shares
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.00
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.00
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.07
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.07
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.08
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.08
CY2024 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1709653 shares
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1683564 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1787808 shares

Files In Submission

Name View Source Status
0001688757-25-000019-index-headers.html Edgar Link pending
0001688757-25-000019-index.html Edgar Link pending
0001688757-25-000019.txt Edgar Link pending
0001688757-25-000019-xbrl.zip Edgar Link pending
esta-20241231.htm Edgar Link pending
esta-20241231.xsd Edgar Link pending
esta-20241231_g1.jpg Edgar Link pending
esta-20241231_g10.jpg Edgar Link pending
esta-20241231_g11.jpg Edgar Link pending
esta-20241231_g12.jpg Edgar Link pending
esta-20241231_g13.jpg Edgar Link pending
esta-20241231_g2.jpg Edgar Link pending
esta-20241231_g3.jpg Edgar Link pending
esta-20241231_g4.jpg Edgar Link pending
esta-20241231_g5.jpg Edgar Link pending
esta-20241231_g6.jpg Edgar Link pending
esta-20241231_g7.jpg Edgar Link pending
esta-20241231_g8.jpg Edgar Link pending
esta-20241231_g9.jpg Edgar Link pending
esta10k-exhibit191q4_2024.htm Edgar Link pending
esta10k-exhibit211q4_2024.htm Edgar Link pending
esta10k-exhibit231q4_2024.htm Edgar Link pending
esta10k-exhibit311q4_2024.htm Edgar Link pending
esta-20241231_cal.xml Edgar Link unprocessable
esta-20241231_def.xml Edgar Link unprocessable
esta-20241231_pre.xml Edgar Link unprocessable
esta-20241231_htm.xml Edgar Link completed
esta10k-exhibit312q4_2024.htm Edgar Link pending
esta10k-exhibit321q4_2024.htm Edgar Link pending
estainsidertradingpolicy_p.jpg Edgar Link pending
estainsidertradingpolicy_pa.jpg Edgar Link pending
estainsidertradingpolicy_pb.jpg Edgar Link pending
estainsidertradingpolicy_pc.jpg Edgar Link pending
estainsidertradingpolicy_pd.jpg Edgar Link pending
estainsidertradingpolicy_pe.jpg Edgar Link pending
estainsidertradingpolicy_pf.jpg Edgar Link pending
estainsidertradingpolicy_pg.jpg Edgar Link pending
estainsidertradingpolicy_ph.jpg Edgar Link pending
estainsidertradingpolicy_pi.jpg Edgar Link pending
estainsidertradingpolicy_pj.jpg Edgar Link pending
estainsidertradingpolicy_pk.jpg Edgar Link pending
estainsidertradingpolicy_pl.jpg Edgar Link pending
estainsidertradingpolicy_pm.jpg Edgar Link pending
estainsidertradingpolicy_pn.jpg Edgar Link pending
estainsidertradingpolicy_po.jpg Edgar Link pending
estainsidertradingpolicy_pp.jpg Edgar Link pending
estainsidertradingpolicy_pq.jpg Edgar Link pending
estainsidertradingpolicy_pr.jpg Edgar Link pending
estainsidertradingpolicy_ps.jpg Edgar Link pending
estainsidertradingpolicy_pt.jpg Edgar Link pending
estainsidertradingpolicy_pu.jpg Edgar Link pending
estainsidertradingpolicy_pv.jpg Edgar Link pending
estainsidertradingpolicy_pw.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
esta-20241231_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable